Biological
In an international effort to reduce global catastrophic risks associated with technological advancements, the Nuclear Threat Initiative (NTI) has established a multi-year project that will develop and promote actions that limit the potential misuse of biotechnology.
Launched last month, the NTI... Read More »
Against the backdrop of a spreading Ebola outbreak in Congo, where a worsening war has stymied U.S. aid amid increasing security concerns, the Trump administration is trying to wrap its arms around what is and isn’t working in biodefense against man-made, accidental, naturally occurring... Read More »
Rapidly evolving wearables and 3D printed devices are among the inexpensive and portable diagnostic tools on the market today, some of which can detect and diagnose disease in less than an hour for biosurveillance.
However, developing these devices on a much greater scale for biosecurity... Read More »
The U.S. Department of Homeland Security’s (DHS) Science and Technology Directorate (S&T) has opened submissions for its Biometric Technology Rally that will be held in the spring.
Biometric systems include fingerprint, iris or face recognition.
The rally challenges participants to develop... Read More »
Combating diseases such as Ebola, influenza, and a host of other global catastrophic biological risks could be addressed by 15 emerging technologies, many of which are easy to use, high-tech and low cost.
In “Technologies to Address Global Catastrophic Biological Risks,” the report issued... Read More »
A federal grand jury in Salt Lake City recently indicted William Clyde Allen, III, of Logan, Utah, on seven counts in connection with ricin-related threats.
While Allen pleaded not guilty, the indictment alleges Allen knowingly used ricin as a weapon, mailed a threat against President Donald... Read More »
The Department of Health and Human Services (DHHS) announced this week that a strategic partnership between the department and Johnson & Johnson will seek to advance efforts against chemical, biological, radiation, nuclear, disease, and antimicrobial threats in the United States.
The two... Read More »
A large-scale biological event shouldn’t mean that the nation’s thousands of state, local, tribal, and territorial (SLTT) governments fend for themselves waiting for federal assets to arrive, a new bipartisan report of the Blue Ribbon Study Panel on Biodefense says.
“We can take steps now... Read More »
As a founding director of the nation’s first bioterrorism preparedness program at the Centers for Disease Control and Prevention in 1999, Dr. Scott Lillibridge didn’t realize then what would emerge as the almost surreal scope of biothreats now challenging the United States.
But now he knows,... Read More »
The Chinese government is investing more than the United States in the use of non-human primates as laboratory models for deadly infectious disease research, according to expert testimony delivered on Tuesday during a meeting of the Blue Ribbon Study Panel on Biodefense.
Jay Rappaport, director... Read More »
Texas A&M University was selected to lead a consortium of U.S. academic institutions, among others, for a new Center of Excellence (COE) for Cross-Border Threat Screening and Supply Chain Defense (CBTS).
The project will be funded by a $3.85 million grant from the U.S. Department of Homeland... Read More »
In 2015 it was discovered that a U.S. laboratory spent more than a decade inadvertently sending the bacteria that causes anthrax to 194 laboratories worldwide.
The U.S. Government Accountability Office has recently released its findings regarding how effective the U.S. Department of Defense has... Read More »
The U.S. House of Representatives on Tuesday advanced bipartisan legislation sponsored by U.S. Rep. Susan Brooks (R-IN) to bolster America’s preparedness and response to public health emergencies, including biological threats like emerging infectious diseases, as well as chemical, bio or nuclear... Read More »
Fiji is subjected to a smallpox outbreak where social norms breakdown and medical experts scramble to get the outbreak under control.
This wasn’t reality, but it was the simulation exercise for participants of a workshop held last month at the University of New South Wales Sydney. The event... Read More »
Researchers from Imperial College London are taking a new tack in the battle against malaria, focusing on
the compounds that could prevent malaria parasites from being able to infect mosquitoes, halting the spread of disease.
As a disease delivery system, mosquitoes are infamous, but... Read More »
The Sept. 18 release of the 2018 National Biodefense Strategy and a newly signed National Security Presidential Memorandum (NSPM) will bolster the nation’s defenses against man-made, accidental or intentional, and naturally occurring biological threats to Americans’ health and safety, said U.S.... Read More »
Eric Moore, director of the U.S. Army Research, Development and Engineering Command Chemical & Biological Center (RDECOM C&B) recently spoke at an industry conference about technology and innovation in development to bolster chemical and biological defense.
The CBRN (chemical, biological,... Read More »
As the World Health Organization (WHO) and health agencies in the Democratic Republic of the Congo (DRC) seek to clamp down quickly on a new Ebola outbreak in the country, they can now count on the expertise of the U.S. Centers for Disease Control and Prevention (CDC) as well.
The CDC has... Read More »
Researchers are still a decade away from seeing a Valley Fever vaccine realized for humans, who are in recent years being infected at a greater degree with the fungal spores that cause the disease. The illness primarily affects people living in the Southwestern United States.
Federal officials... Read More »
Two national organizations that represent biopharmaceutical and business interests have penned a letter to each member of the U.S. House of Representatives urging lawmakers to approve the Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018, H.R. 6378, before critical public... Read More »
The global spread of a deadly disease outbreak during a biological attack would impact far more than U.S. government financial resources, former federal lawmakers say, and could crash the coffers of local and state budgets just as severely.
“We know unequivocally that terrorists have the... Read More »
Developing drugs for rapid response to treat emerging infectious diseases requires overcoming numerous hurdles.
For a start, there are few large-scale pharmaceutical campaigns. The reality is quite the opposite, as it can be a challenge for the government to convince pharmaceutical companies to... Read More »
Marines and Illinois response units recently joined forces to share training techniques designed to enhance chemical and biological emergency preparedness.
Marines and sailors with the Chemical Biological Incident Response Force (CBRIF) participated in Exercise Chicago Response in Chicago,... Read More »
Nuclear Threat Initiative (NTI) officials will be participating in several discussion panels presented at the Institute of Nuclear Materials Management’s (INMM) 59th annual meeting this week in Baltimore, Md.
NTI Vice President Corey Hinderstein provided opening remarks at the first plenary... Read More »
It would cost the U.S. government only half a day’s worth of federal spending — anywhere between $5 billion and $6 billion — to create the infrastructure needed to counteract the threat of chemical or biological attacks, according to findings described in “Invisible Scourge: The Danger of... Read More »
A comprehensive update to the nation’s soon-to-expire pandemic and all-hazards law has been unveiled in the U.S. House where Energy and Commerce Committee members have painstakingly produced a bipartisan reauthorization to bolster America’s defense against chemical, biological, radiological or... Read More »
The U.S. Food and Drug Administration has recently approved a new drug for the treatment of smallpox, a pill stockpiled in case the virus is used as a bioweapon.
TPOXX, a small-molecule antiviral treatment, is the first therapy approved for this biosecurity use and was developed by SIGA... Read More »
The U.S. House Energy and Commerce Health Subcommittee on June 27 passed the Pandemic and All Hazards Preparedness Reauthorization Act of 2018 (PAHPRA), sending it to the full committee along with four other public health bills under consideration.
“The mark up of these five important bills... Read More »
The hectic nature of public health emergencies may hardly leave officials time to reflect on what lessons are being learned on the ground, and in real time.
The Outbreak Observatory aims to change that.
Comprised of experts in public health and biosecurity, the Observatory’s team captures... Read More »
The Nuclear Threat Initiative (NTI) Global Biosecurity Dialogue (GBD) brought more than 60 government officials, international organizations, nuclear experts and civil society leaders together in London last week to discuss solutions to strengthen global biosecurity and biosafety.... Read More »
The Nuclear Threat Initiative (NTI) launched an advisory group for its recently expanded Global Biological Policy and Programs.
The advisory group provides strategic guidance on the program’s effort to reduce global biological risks. It will be chaired by former commissioner of the Food and... Read More »
The United States may be prepared for emerging biological terror and disease outbreaks, but members of Congress questioned during a recent hearing whether coordination among federal agencies, local health departments, and private companies are optimal to tackle such threats.
The purpose of... Read More »
Officers in the Epidemic Intelligence Service (EIS), a program of the Centers for Disease Control and Prevention, have for seven decades tackled some of the most pressing public health challenges in the United States and abroad.
However, student loans might deter many potential EIS officers, who... Read More »
The U.S. Department of Homeland Security (DHS) recently named the “Pandemic Pulse” intuitive dashboard developed by the Computational Epidemiology Lab at Boston Children’s Hospital as the $150,000 grand prize winner of the Hidden Signals Challenge.
Launched in October by the DHS Science &... Read More »
Emergent BioSolutions Inc. plans to undertake a three-year, $50 million project that will expand the contract development and manufacturing capacity of the company’s Camden fill/finish facility in Baltimore.
Slated for completion in 2021, the expansion project also aims to address... Read More »
